Effects of spin labeled derivatives of podophyllotoxin on cell cycle and macromolecular synthesis in human lymphoid leukemia Molt 4B cells

Acta Pharmacologica Sinica

Volumn 19, Issue 6, 1998, Pages 501-505

  Wang, Jun Zhi ^a   Tsumura, Hideki ^b   Shlmura, Keishiro ^b   Tian, Xuan ^c   Ito, Hitoshi ^b  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b MIE UNIVERSITY   (Japan)

^c LANZHOU UNIVERSITY   (China)

Author keywords

Cell cycle; Cultured tumor cells; Etoposide; Lymphocytic leukemia; Podophyllotoxin; Spin labels

Indexed keywords

4 (2,2,6,6 TETRAMETHYL 1 OXYL 4 PIPERIDYLAMINO) 4' NOREPIPODOPHYLLOTOXIN; 4 CINNAMYL 1 PIPERAZINECARBOXAMIDINE; ETOPOSIDE; PODOPHYLLOTOXIN; PODOPHYLLOTOXIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; MACROMOLECULE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; ETOPOSIDE; HUMANS; LEUKEMIA, LYMPHOCYTIC; MITOTIC INDEX; NEOPLASM PROTEINS; PODOPHYLLOTOXIN; TUMOR CELLS, CULTURED;

EID: 0031741296     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Leff RS, Thomoson JM, Daly MB, Johnson DB, Harden EA, Mercier RJ, et al. Acute neurological dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 1988; 62: 32 - 5.
2. Shimizu H, Frankel LS, Culbert SJ. Severe hypertensive reaction to teniposide (VM-26) in infants with congenital leukemia. Am J Pediatr Hematal Oncol 1987; 9: 239 - 41.
3. Chen YZ, Wang YG, Li JX, Tian X, Jia ZP, Zhang PY Anticancer drugs II. Synthesis and biological evaluation of spin labeled derivatives of podophyllotoxin. Life Sci 1989; 45: 2569 - 75.
4. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987; 47: 936 - 42.
5. Wang JZ, Tian X, Tsumura H, Shimura K, Ito H. Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms. Anti-Cancer Drug Design 1993; 8: 193 - 202.
6. Kalwinsky DK, Look AT, Ducore J, Fridland A. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res 1983; 43: 1592 - 7.
7. Van Maanen JM, Van Den Akker E, De Vries J, Bakkenist TR, Larkelma J, Retel J, et al. Structure-bioactivation relationship of a series of podophyllotoxin derivatives. Eur J Cancer Clin Oncol 1988; 24: 1415 - 19.
8. Emanuel NM, Konovalova NP, Djachkovskaya RF. Texicity. antitumor activity, and pharmacokinetics of spin-labeled thioTEPA analogs. Cancer Treat Rep 1976; 60: 1605 - 9.
9. Wang Y, Dan J, SHI J, Chen Y. New spin labeled analogues of podophyllotoxin as potential antitumor agents. Life Sci 1997; 61: 537 - 42.